Accenture Shares Fall After Warning DOGE Cost Cuts Are Hurting Sales
Accenture Plc shares tumbled after the consultancy said its US government work has slowed amid Elon Musk's cost-cutting push.
The company, with nearly 800,000 employees around the world, said new procurement actions had decreased amid President Donald Trump's spending crackdown, hurting its sales and revenue. Accenture Chief Executive Officer Julie Sweet said on a call discussing earnings that federal services accounted for about 8% of its global revenue and about 16% of its Americas revenue in the 2024 fiscal year.
The company reported $16.7 billion of revenue in the three months through February, a 5% increase on the prior year. Accenture's shares fell by more than 10%, the most since March 2020, before paring some of those losses.
Musk's Department of Government Efficiency has taken aim at consulting deals as an example of what the administration deems wasteful spending. The government has told all federal agencies to review their contracts with the 10 highest-paid consulting firms that do work with the government, including Accenture. Agencies were given until March 14 to justify their contracts with the firms, Bloomberg has reported.
“While we continue to believe our work for federal clients is mission critical, we anticipate ongoing uncertainty as the government's priorities evolve and these assessments unfold,” Sweet said.
Accenture also said it updated the so-called risk factors in its annual report to include that government work “exposes us to additional risks inherent in the government contracting environment.”
So far, the General Services Administration — the US federal procurement agency — has canceled 1,700 consulting contracts resulting in $4.5 billion in savings, Bloomberg reported this month.
“We are seeing an elevated level of what was already significant uncertainty in the global economic and geopolitical environment,” Sweet said. “At the same time, we believe the fundamentals of our industry remain strong and we are very well-positioned with our clients.”
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.